Ozempic-like drugs found to be safe and effective for children with obesity, without diabetes

New probe being presented astatine the International Congress connected Obesity (ICO2026), hosted by the World Obesity Federation (WOF) successful Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for value nonaccomplishment successful children of assorted ages without diabetes are harmless and effective. The survey is by Dr. Manpreet Kaur Oberoi of the University of Western Ontario successful London, Ontario, Canada, and colleagues.